Literature DB >> 30022399

Recurrent pericarditis: still idiopathic? The pros and cons of a well-honoured term.

Antonio Brucato1, Massimo Imazio2, Paul C Cremer3, Yehuda Adler4, Bernhard Maisch5, George Lazaros6, Marco Gattorno7, Alida L P Caforio8, Renzo Marcolongo9, Giacomo Emmi10, Alberto Martini7,11, Allan L Klein3.   

Abstract

In developed countries, more than 80% of cases of acute pericarditis remain without an established diagnosis after a conventional and standard diagnostic approach. These cases are generally labelled as 'idiopathic', i.e. without a known cause. This lack of information is a matter of concern for both patients and clinicians. Some years ago, this term reflected the state of the art of scientific knowledge on the topic. Advances have changed this point of view, in light of available molecular techniques like polymerase chain reaction able to identify viral cardiotropic agents in pericardial fluid and biopsies. Furthermore, the remarkable efficacy of interleukin-1 antagonists, a therapy targeting the innate immune response, suggests clinical and pathogenic similarity between a proportion of patients with idiopathic recurrent pericarditis and classical autoinflammatory diseases. So, it seems useful to discuss the pros and cons of using the term "idiopathic" in light of the new knowledge.

Entities:  

Keywords:  Anakinra; Autoinflammatory diseases; IL-1 antagonists; Idiopathic recurrent pericarditis; Innate immune system; Pericarditis

Mesh:

Year:  2018        PMID: 30022399     DOI: 10.1007/s11739-018-1907-x

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  39 in total

1.  Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study.

Authors:  Luca Cantarini; Orso Maria Lucherini; Antonio Brucato; Luca Barone; Davide Cumetti; Francesca Iacoponi; Donato Rigante; Giovanni Brambilla; Silvana Penco; Maria Giuseppina Brizi; Maria Cristina Patrosso; Guido Valesini; Bruno Frediani; Mauro Galeazzi; Rolando Cimaz; Giuseppe Paolazzi; Antonio Vitale; Massimo Imazio
Journal:  Clin Res Cardiol       Date:  2012-02-05       Impact factor: 5.460

2.  Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis.

Authors:  A L P Caforio; A Brucato; A Doria; G Brambilla; A Angelini; A Ghirardello; S Bottaro; F Tona; C Betterle; L Daliento; G Thiene; S Iliceto
Journal:  Heart       Date:  2010-05       Impact factor: 5.994

3.  Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial.

Authors:  Antonio Brucato; Massimo Imazio; Marco Gattorno; George Lazaros; Silvia Maestroni; Mara Carraro; Martina Finetti; Davide Cumetti; Alessandra Carobbio; Nicolino Ruperto; Renzo Marcolongo; Monia Lorini; Alessandro Rimini; Anna Valenti; Gian Luca Erre; Maria Pia Sormani; Riccardo Belli; Fiorenzo Gaita; Alberto Martini
Journal:  JAMA       Date:  2016-11-08       Impact factor: 56.272

4.  Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients.

Authors:  A Brucato; Y Shinar; G Brambilla; L Robbiolo; G Ferrioli; M C Patrosso; D Zanni; S Penco; E Boiani; A Ghirardello; A L P Caforio; A Bergantin; V Tombini; A Moreo; L Ashtamkar; A Doria; Y Shoenfeld; A Livneh
Journal:  Lupus       Date:  2005       Impact factor: 2.911

Review 5.  Recurrent Pericarditis.

Authors:  Massimo Imazio; Elena Gribaudo; Fiorenzo Gaita
Journal:  Prog Cardiovasc Dis       Date:  2016-10-07       Impact factor: 8.194

6.  Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance.

Authors:  Massimo Imazio; Antonio Brucato; Andrea Doria; Giovanni Brambilla; Anna Ghirardello; Alessandra Romito; Giuseppe Natale; Giancarlo Palmieri; Rita Trinchero; Yehuda Adler
Journal:  Int J Cardiol       Date:  2008-07-31       Impact factor: 4.164

7.  Social networking in online support groups for health: how online social networking benefits patients.

Authors:  Jae Eun Chung
Journal:  J Health Commun       Date:  2013-04-04

8.  Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children.

Authors:  Seza Ozen; Erkan Demirkaya; Gayane Amaryan; Isabelle Koné-Paut; Adem Polat; Pat Woo; Yosef Uziel; Consuelo Modesto; Martina Finetti; Pierre Quartier; Efimia Papadopoulou-Alataki; Sulaiman M Al-Mayouf; Giovanna Fabio; Romina Gallizzi; Luca Cantarini; Joost Frenkel; Susan Nielsen; Michael Hofer; Antonella Insalaco; C Acikel; Huri Ozdogan; Alberto Martini; Nicolino Ruperto; Marco Gattorno
Journal:  Ann Rheum Dis       Date:  2013-03-05       Impact factor: 19.103

Review 9.  Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism.

Authors:  Antonio Brucato; Giacomo Emmi; Luca Cantarini; Andrea Di Lenarda; Marco Gattorno; Giuseppe Lopalco; Renzo Marcolongo; Massimo Imazio; Alberto Martini; Domenico Prisco
Journal:  Intern Emerg Med       Date:  2018-04-09       Impact factor: 3.397

10.  Indicators of poor prognosis of acute pericarditis.

Authors:  Massimo Imazio; Enrico Cecchi; Brunella Demichelis; Salvatore Ierna; Daniela Demarie; Aldo Ghisio; Franco Pomari; Luisella Coda; Riccardo Belli; Rita Trinchero
Journal:  Circulation       Date:  2007-05-14       Impact factor: 29.690

View more
  13 in total

1.  Successful use of anakinra for colchicine-intolerant, corticosteroid-dependent recurrent pericarditis secondary to postcardiac injury syndrome after pacemaker placement.

Authors:  Muhammad Hamza Saad Shaukat; Muhammad Asim Shabbir; Sulagna Mookherjee; Ruben Peredo-Wende
Journal:  BMJ Case Rep       Date:  2019-04-04

2.  [Management of pericarditis and pericardial effusion, constrictive and effusive-constrictive pericarditis].

Authors:  B Maisch
Journal:  Herz       Date:  2018-11       Impact factor: 1.443

Review 3.  Autoimmune and Autoinflammatory Pericarditis: Definitions and New Treatments.

Authors:  Emanuele Bizzi; Lucia Trotta; Massimo Pancrazi; Mariangela Nivuori; Valeria Giosia; Luca Matteucci; Daniela Montori; Antonio Brucato
Journal:  Curr Cardiol Rep       Date:  2021-07-28       Impact factor: 2.931

4.  Clinical significance of pleural effusions and association with outcome in patients hospitalized with a first episode of acute pericarditis.

Authors:  George Lazaros; Alexios S Antonopoulos; Massimo Imazio; Eirini Solomou; Emilia Lazarou; Dimitrios Vassilopoulos; Yehuda Adler; Christodoulos Stefanadis; Dimitris Tousoulis
Journal:  Intern Emerg Med       Date:  2019-03-13       Impact factor: 3.397

Review 5.  Idiopathic Pericarditis-an Autoinflammatory Disease?

Authors:  Norbert Blank; Hanns-Martin Lorenz
Journal:  Curr Rheumatol Rep       Date:  2019-03-09       Impact factor: 4.686

Review 6.  Recurrent Pericarditis in Children and Adolescents.

Authors:  Enrico Tombetti; Teresa Giani; Antonio Brucato; Rolando Cimaz
Journal:  Front Pediatr       Date:  2019-10-18       Impact factor: 3.418

7.  Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial.

Authors:  Allan L Klein; David Lin; Paul C Cremer; Saifullah Nasir; Sushil Allen Luis; Antonio Abbate; Andrew Ertel; Martin LeWinter; Anna Beutler; Fang Fang; John F Paolini
Journal:  Heart       Date:  2020-11-23       Impact factor: 5.994

8.  Health-related quality of life in patients with recurrent pericarditis: results from a phase 2 study of rilonacept.

Authors:  David Lin; Allan Klein; David Cella; Anna Beutler; Fang Fang; Matt Magestro; Paul Cremer; Martin M LeWinter; Sushil Allen Luis; Antonio Abbate; Andrew Ertel; Leighann Litcher-Kelly; Brittany Klooster; John F Paolini
Journal:  BMC Cardiovasc Disord       Date:  2021-04-21       Impact factor: 2.298

9.  Acute pericarditis or a systemic disease with pleuropulmonary involvement?

Authors:  Maddalena Alessandra Wu; Nathalie Costedoat-Chalumeau; Silvia Maestroni; Antonio Brucato
Journal:  Intern Emerg Med       Date:  2019-02-21       Impact factor: 3.397

Review 10.  Novel Pharmacotherapies for Recurrent Pericarditis: Current Options in 2020.

Authors:  Enrico Tombetti; Alice Mulè; Silvia Tamanini; Luca Matteucci; Enrica Negro; Antonio Brucato; Carla Carnovale
Journal:  Curr Cardiol Rep       Date:  2020-06-19       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.